Clinical Trials Logo

Filter by:
NCT ID: NCT00665847 Completed - HIV-1 Clinical Trials

TMC125-TiDP35-C213: Safety and Antiviral Activity of Etravirine (TMC125) in Treatment-Experienced, HIV Infected Children and Adolescents

Start date: November 2008
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine the safety and antiviral activity of etravirine in treatment-experienced human immunodeficiency virus (HIV) infected children and adolescents.

NCT ID: NCT00665639 Completed - Candidiasis, Oral Clinical Trials

Trial of Two Dosing Regimens of Micafungin Versus Caspofungin for the Treatment of Esophageal Candidiasis

Start date: June 2004
Phase: Phase 3
Study type: Interventional

To determine the efficacy and safety of daily doses of IV micafungin versus IV caspofungin for the treatment of esophageal candidiasis

NCT ID: NCT00664716 Completed - Clinical trials for Rheumatoid Arthritis

Assessment Of The Safety And Efficacy Of BG9924 In Rheumatoid Arthritis (RA) Participants

RESPOND
Start date: July 2007
Phase: Phase 2
Study type: Interventional

Safety and efficacy of BG9924 in RA participants that have had an inadequate response to disease-modifying anti-rheumatic drug (DMARD) therapy.

NCT ID: NCT00664625 Completed - Chronic Hepatitis C Clinical Trials

A Single Ascending Dose Study of BMS-791325 in HCV Infected Subjects

Start date: May 2008
Phase: Phase 1/Phase 2
Study type: Interventional

The primary purpose of this study is to evaluate the safety profile and tolerability of single oral doses of BMS-791325 in subjects with chronic hepatitis C infection

NCT ID: NCT00664573 Terminated - Clinical trials for Rheumatoid Arthritis

104RA204 Assessment of the Safety and Efficacy of BG9924 in Rheumatoid Arthritis (RA) Participants

RESPOND-EXT
Start date: November 2007
Phase: Phase 2
Study type: Interventional

To observe the long-term treatment with BG9924 when administered to participants with RA who previously participated in a Biogen Idec Study.

NCT ID: NCT00664170 Completed - Advanced Cancer Clinical Trials

A Bioequivalence Study of Docetaxel for Injectable Emulsion (ANX-514) in Patients With Advanced Cancer

Start date: April 2008
Phase: Phase 1
Study type: Interventional

The purpose of this study is to compare an injectable emulsion form of docetaxel to Taxotere in patients with advanced cancer.

NCT ID: NCT00663260 Completed - Clinical trials for Diabetes Mellitus, Type 2

Glycemic Efficacy and Renal Safety Study of Dapagliflozin in Subjects With Type 2 Diabetes Mellitus and Moderate Renal Impairment

Start date: June 2008
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is to determine whether dapagliflozin is effective in the treatment of type 2 diabetes in subjects with poor blood sugar control and moderate renal impairment

NCT ID: NCT00663052 Completed - Psoriasis Clinical Trials

Study Evaluating Etanercept for the Treatment of Moderate to Severe Psoriasis

PRISTINE
Start date: June 2008
Phase: Phase 4
Study type: Interventional

The purpose of this study is to compare the safety and efficacy of different doses of etanercept for the treatment of moderate to severe psoriasis.

NCT ID: NCT00662597 Terminated - Clinical trials for Non-Small Cell Lung Cancer

ASA404 or Placebo in Combination With Paclitaxel and Carboplatin as First-Line Treatment for Stage IIIb/IV Non-Small Cell Lung Cancer

ATRACT-1
Start date: April 2008
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine if adding ASA404 to standard chemotherapy makes the cancer treatment more effective in patients with advanced lung cancer.

NCT ID: NCT00660907 Completed - Type 2 Diabetes Clinical Trials

Efficacy and Safety of Dapagliflozin in Combination With Metformin in Type 2 Diabetes Patients

Start date: March 2008
Phase: Phase 3
Study type: Interventional

This study is being carried out to see if dapagliflozin as an addition to metformin is effective and safe in treating patients with type 2 diabetes when compared to glipizide (sulphonylurea) as an addition to metformin treatment.